Dr. Kelly Tappenden interviews Dr. Johanna Eliasson, Department of Intestinal Failure and Liver Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, discussing her paper “Apraglutide, a novel glucagon-like peptide 2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial”.

Business Corporate by Alex Menco | alexmenco.net

Music promoted by www.free-stock-music.com

Creative Commons Attribution 3.0 Unported License

creativecommons.org/licenses/by/3.0/deed.en_US

May 2022